Annabel Samimy
Stock Analyst at Stifel
(3.38)
# 826
Out of 4,814 analysts
56
Total ratings
42.31%
Success rate
24.62%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Annabel Samimy
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LGND Ligand Pharmaceuticals | Initiates: Buy | $143 | $105.28 | +35.83% | 1 | Apr 10, 2025 | |
| PVLA Palvella Therapeutics | Initiates: Buy | $45 | $24.24 | +85.64% | 1 | Mar 26, 2025 | |
| GPCR Structure Therapeutics | Initiates: Buy | $50 | $21.69 | +130.57% | 1 | Jan 8, 2025 | |
| ALT Altimmune | Initiates: Buy | $18 | $4.54 | +296.48% | 1 | Jan 8, 2025 | |
| IVA Inventiva | Maintains: Buy | $20 → $17 | $3.36 | +405.95% | 4 | Nov 22, 2024 | |
| MBX MBX Biosciences | Initiates: Buy | $40 | $7.63 | +424.25% | 1 | Oct 8, 2024 | |
| KMDA Kamada | Initiates: Buy | $18 | $6.53 | +175.86% | 1 | Jul 3, 2024 | |
| PHAT Phathom Pharmaceuticals | Initiates: Buy | $24 | $4.08 | +488.24% | 1 | May 3, 2024 | |
| RGNX REGENXBIO | Maintains: Buy | $40 | $5.96 | +571.14% | 2 | Apr 12, 2024 | |
| VKTX Viking Therapeutics | Reiterates: Buy | $80 | $23.83 | +235.71% | 6 | Mar 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $225 → $230 | $102.02 | +125.45% | 8 | Mar 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $23 → $25 | $10.80 | +131.59% | 1 | Mar 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $35 | $18.03 | +94.12% | 1 | Oct 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $60 → $65 | $18.17 | +257.73% | 3 | Aug 29, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $28 → $11 | $0.29 | +3,680.07% | 4 | Jun 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $45 | $13.26 | +239.49% | 1 | Mar 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $8 | $0.86 | +834.36% | 1 | Nov 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $24 | $1.15 | +1,986.96% | 1 | Aug 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $20 | $29.10 | -31.27% | 1 | Apr 24, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $700 → $750 | $1.00 | +74,900.00% | 3 | Apr 16, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $25 → $24 | $30.78 | -22.03% | 7 | Apr 16, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $15 → $21 | $0.72 | +2,816.67% | 6 | Sep 18, 2019 |
Ligand Pharmaceuticals
Apr 10, 2025
Initiates: Buy
Price Target: $143
Current: $105.28
Upside: +35.83%
Palvella Therapeutics
Mar 26, 2025
Initiates: Buy
Price Target: $45
Current: $24.24
Upside: +85.64%
Structure Therapeutics
Jan 8, 2025
Initiates: Buy
Price Target: $50
Current: $21.69
Upside: +130.57%
Altimmune
Jan 8, 2025
Initiates: Buy
Price Target: $18
Current: $4.54
Upside: +296.48%
Inventiva
Nov 22, 2024
Maintains: Buy
Price Target: $20 → $17
Current: $3.36
Upside: +405.95%
MBX Biosciences
Oct 8, 2024
Initiates: Buy
Price Target: $40
Current: $7.63
Upside: +424.25%
Kamada
Jul 3, 2024
Initiates: Buy
Price Target: $18
Current: $6.53
Upside: +175.86%
Phathom Pharmaceuticals
May 3, 2024
Initiates: Buy
Price Target: $24
Current: $4.08
Upside: +488.24%
REGENXBIO
Apr 12, 2024
Maintains: Buy
Price Target: $40
Current: $5.96
Upside: +571.14%
Viking Therapeutics
Mar 15, 2024
Reiterates: Buy
Price Target: $80
Current: $23.83
Upside: +235.71%
Mar 15, 2024
Maintains: Buy
Price Target: $225 → $230
Current: $102.02
Upside: +125.45%
Mar 8, 2024
Reiterates: Buy
Price Target: $23 → $25
Current: $10.80
Upside: +131.59%
Oct 5, 2023
Initiates: Buy
Price Target: $35
Current: $18.03
Upside: +94.12%
Aug 29, 2023
Maintains: Buy
Price Target: $60 → $65
Current: $18.17
Upside: +257.73%
Jun 26, 2023
Downgrades: Hold
Price Target: $28 → $11
Current: $0.29
Upside: +3,680.07%
Mar 7, 2023
Initiates: Buy
Price Target: $45
Current: $13.26
Upside: +239.49%
Nov 10, 2022
Upgrades: Buy
Price Target: $8
Current: $0.86
Upside: +834.36%
Aug 24, 2021
Initiates: Buy
Price Target: $24
Current: $1.15
Upside: +1,986.96%
Apr 24, 2020
Initiates: Hold
Price Target: $20
Current: $29.10
Upside: -31.27%
Apr 16, 2020
Maintains: Buy
Price Target: $700 → $750
Current: $1.00
Upside: +74,900.00%
Apr 16, 2020
Maintains: Hold
Price Target: $25 → $24
Current: $30.78
Upside: -22.03%
Sep 18, 2019
Maintains: Hold
Price Target: $15 → $21
Current: $0.72
Upside: +2,816.67%